These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
491 related articles for article (PubMed ID: 23067268)
1. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer. Adamsson J; Lundin SB; Hansson LE; Sjövall H; Svennerholm AM Helicobacter; 2013 Feb; 18(1):73-82. PubMed ID: 23067268 [TBL] [Abstract][Full Text] [Related]
2. Disparity between mucosal and serum IgA and IgG in Helicobacter pylori infection. Schmausser B; Eck M; Greiner A; Lührs H; Vollmers HP; Müller-Hermelink HK Virchows Arch; 2002 Aug; 441(2):143-7. PubMed ID: 12189503 [TBL] [Abstract][Full Text] [Related]
3. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer. Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020 [TBL] [Abstract][Full Text] [Related]
4. Anti Helicobacter pylori IgG and IgA response in patients with gastric cancer and chronic gastritis. Manojlovic N; Babic D; Filipovic-Ljeshovic I; Pilcevic D Hepatogastroenterology; 2008; 55(82-83):807-13. PubMed ID: 18613460 [TBL] [Abstract][Full Text] [Related]
5. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease. Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680 [TBL] [Abstract][Full Text] [Related]
7. [Relation between infection of CagA-positive Helicobacter pylori and upper gastrointestinal diseases]. Yang G; Hu F; Jia J Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):648-50. PubMed ID: 11798940 [TBL] [Abstract][Full Text] [Related]
8. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence. Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014 [TBL] [Abstract][Full Text] [Related]
9. Local and systemic immune responses in humans against Helicobacter pylori antigens from homologous and heterologous strains. Tinnert A; Mattsson A; Bölin I; Dalenbäck J; Hamlet A; Svennerholm AM Microb Pathog; 1997 Nov; 23(5):285-96. PubMed ID: 9405206 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of IgG antibody titer against Helicobacter pylori. Tatemichi M; Sasazuki S; Inoue M; Tsugane S; Helicobacter; 2009 Jun; 14(3):231-6. PubMed ID: 19702853 [TBL] [Abstract][Full Text] [Related]
12. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status. Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643 [TBL] [Abstract][Full Text] [Related]
13. Serum Helicobacter pylori IgG and IgA levels in patients with gastric cancer. Atalay C; Atalay G; Altinok M Neoplasma; 2003; 50(3):185-90. PubMed ID: 12937851 [TBL] [Abstract][Full Text] [Related]
14. Decreased IgA antibody production in the stomach of gastric adenocarcinoma patients. Quiding-Järbrink M; Sundström P; Lundgren A; Hansson M; Bäckström M; Johansson C; Enarsson K; Hermansson M; Johnsson E; Svennerholm AM Clin Immunol; 2009 Jun; 131(3):463-71. PubMed ID: 19249247 [TBL] [Abstract][Full Text] [Related]
15. Mucosal and systemic antibody levels against Helicobacter pylori do not parallel gastric inflammatory changes. Luzza F; Maletta M; Imeneo M; Marcheggiano A; Biancone L; Pallone F Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):36-9. PubMed ID: 9615262 [TBL] [Abstract][Full Text] [Related]
16. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies. Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521 [TBL] [Abstract][Full Text] [Related]
17. Tissue IgA antibody against Helicobacter pylori in patients with gastroduodenal diseases: comparison with bacterial culture, serum IgG antibody, and [13C]Urea breath test. Matsukura N; Onda M; Tokunaga A; Kato S; Kyono S; Yamashita K J Clin Gastroenterol; 1995; 21 Suppl 1():S146-50. PubMed ID: 8775008 [TBL] [Abstract][Full Text] [Related]
18. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori. Suzuki G; Cullings H; Fujiwara S; Hattori N; Matsuura S; Hakoda M; Akahoshi M; Kodama K; Tahara E Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1224-8. PubMed ID: 17548689 [TBL] [Abstract][Full Text] [Related]
19. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases. Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700 [TBL] [Abstract][Full Text] [Related]
20. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. Beales IL; Crabtree JE; Scunes D; Covacci A; Calam J Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):645-9. PubMed ID: 8853252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]